112 related articles for article (PubMed ID: 21054401)
21. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
[TBL] [Abstract][Full Text] [Related]
22. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat.
Wegener JW; Gath I; Förstermann U; Nawrath H
Br J Pharmacol; 1997 Dec; 122(7):1523-9. PubMed ID: 9421305
[TBL] [Abstract][Full Text] [Related]
23. [YC-1-like potentiation of nitric oxide-dependent activation of soluble guanylyl cyclase by adrenochrome].
Severina IS; Piatakova NV; Shchegolev AIu; Sidorova TA
Biomed Khim; 2008; 54(6):679-86. PubMed ID: 19205427
[TBL] [Abstract][Full Text] [Related]
24. Human trabecular meshwork cell volume decrease by NO-independent soluble guanylate cyclase activators YC-1 and BAY-58-2667 involves the BKCa ion channel.
Dismuke WM; Sharif NA; Ellis DZ
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3353-9. PubMed ID: 19234350
[TBL] [Abstract][Full Text] [Related]
25. Diazoxide ameliorates microcirculatory disturbances through PKC-dependent pathway in I/R-injured rat cremaster muscles.
Wei W; Wei FC; Hung LM
J Biomed Sci; 2005; 12(3):521-9. PubMed ID: 15959630
[TBL] [Abstract][Full Text] [Related]
26. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].
Severina IS
Biomed Khim; 2007; 53(4):385-99. PubMed ID: 18035720
[TBL] [Abstract][Full Text] [Related]
27. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of extracellular Ca(2+) entry by YC-1, an activator of soluble guanylyl cyclase, through a cyclic GMP-independent pathway in rat neutrophils.
Wang JP; Chang LC; Huang LJ; Kuo SC
Biochem Pharmacol; 2001 Sep; 62(6):679-84. PubMed ID: 11551512
[TBL] [Abstract][Full Text] [Related]
29. Involvement of Ras/Raf-1/p44/42 MAPK in YC-1-induced cyclooxygenase-2 expression in human pulmonary epithelial cells.
Chang MS; Chen BC; Weng CM; Lee WS; Lin CH
Pharmacol Res; 2009 Oct; 60(4):247-53. PubMed ID: 19717011
[TBL] [Abstract][Full Text] [Related]
30. YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components.
Martin E; Lee YC; Murad F
Proc Natl Acad Sci U S A; 2001 Nov; 98(23):12938-42. PubMed ID: 11687640
[TBL] [Abstract][Full Text] [Related]
31. Enhanced responsiveness to nitric oxide, nitroxyl anions, and nitrergic transmitter by 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole in the rat anococcygeus muscle.
Che Y; Ellis A; Li CG
Nitric Oxide; 2005 Sep; 13(2):118-24. PubMed ID: 15993633
[TBL] [Abstract][Full Text] [Related]
32. YC-1 increases cyclo-oxygenase-2 expression through protein kinase G- and p44/42 mitogen-activated protein kinase-dependent pathways in A549 cells.
Chang MS; Lee WS; Teng CM; Lee HM; Sheu JR; Hsiao G; Lin CH
Br J Pharmacol; 2002 Jun; 136(4):558-67. PubMed ID: 12055134
[TBL] [Abstract][Full Text] [Related]
33. Effect of hypothermia and HTK on the microcirculation in the rat cremaster muscle after ischaemia.
Bastiaanse J; Slaaf DW; oude Egbrink MG; Anderson GL; Vink H; van der Heijden BE; Kon M
Clin Sci (Lond); 2005 Jul; 109(1):117-23. PubMed ID: 15610071
[TBL] [Abstract][Full Text] [Related]
34. YC-1-induced cyclooxygenase-2 expression is mediated by cGMP-dependent activations of Ras, phosphoinositide-3-OH-kinase, Akt, and nuclear factor-kappaB in human pulmonary epithelial cells.
Chang MS; Lee WS; Chen BC; Sheu JR; Lin CH
Mol Pharmacol; 2004 Sep; 66(3):561-71. PubMed ID: 15322248
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of active shuttle avoidance response by the NO-cGMP-PKG activator YC-1.
Chien WL; Liang KC; Fu WM
Eur J Pharmacol; 2008 Aug; 590(1-3):233-40. PubMed ID: 18590724
[TBL] [Abstract][Full Text] [Related]
36. Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: structural implication for the YC-1 binding site?
Lamothe M; Chang FJ; Balashova N; Shirokov R; Beuve A
Biochemistry; 2004 Mar; 43(11):3039-48. PubMed ID: 15023055
[TBL] [Abstract][Full Text] [Related]
37. YC-1 stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells.
Liu XM; Peyton KJ; Mendelev NN; Wang H; Tulis DA; Durante W
Mol Pharmacol; 2009 Jan; 75(1):208-17. PubMed ID: 18923065
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the vasorelaxant effects of 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole (YC-1) and diethylamine/nitric oxide (DEA/NO) on the human radial artery used as coronary bypass graft.
Berkan O; Bagcivan I; Kaya T; Yildirim K; Yildirim S; Doğan K
Can J Physiol Pharmacol; 2007 May; 85(5):521-6. PubMed ID: 17632587
[TBL] [Abstract][Full Text] [Related]
39. Binding of YC-1/BAY 41-2272 to soluble guanylate cyclase: A new perspective to the mechanism of activation.
Pal B; Kitagawa T
Biochem Biophys Res Commun; 2010 Jul; 397(3):375-9. PubMed ID: 20513359
[TBL] [Abstract][Full Text] [Related]
40. Impact of gradual blood flow increase on ischaemia-reperfusion injury in the rat cremaster microcirculation model.
Ozmen S; Ayhan S; Demir Y; Siemionow M; Atabay K
J Plast Reconstr Aesthet Surg; 2008 Aug; 61(8):939-48. PubMed ID: 17632046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]